fda approves generic glp 1 Article » ProAct New GLP-1 Pill Foundayo (Orforglipron)

Some studies showed equivalentor even lowertotal weight loss at one year compared to surgery alone

OTC GLP-1 boosters are marketed for weight loss, but pharmacists should help patients distinguish evidence-based care from supplement claims.

This case underscores that standard fasting protocols may not ensure gastric emptying in patients on GLP-1 RA therapy, particularly during medication up-titration or in those with coexisting gastrointestinal motility disorders

Full guide: #GLP1 #Health #WeightLoss #Tips

In the 2026 survey 73.9% (249/337 [95% CIs 69.0-78.4%]) of patients who are eligible for a GLP-1RA who have not used these a GLP-1RA and have expressed an interest in participating in a clinical trial of a GLP-1RA